Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics
Adipose tissue-derived mesenchymal stem cells (ASCs) are recognized as an advantaged source for the prevention and treatment of diverse diseases including type 2 diabetes mellitus (T2DM). However, alterations in characteristics of ASCs from the aforementioned T2DM patients are still obscure, which a...
Gespeichert in:
| Veröffentlicht in: | International journal of stem cells 2020-07, Vol.13 (2), p.268-278 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 278 |
|---|---|
| container_issue | 2 |
| container_start_page | 268 |
| container_title | International journal of stem cells |
| container_volume | 13 |
| creator | Wang, Le Zhang, Leisheng Liang, Xue Zou, Jiaqi Liu, Na Liu, Tengli Wang, Guanqiao Ding, Xuejie Liu, Yaojuan Zhang, Boya Liang, Rui Wang, Shusen |
| description | Adipose tissue-derived mesenchymal stem cells (ASCs) are recognized as an advantaged source for the prevention and treatment of diverse diseases including type 2 diabetes mellitus (T2DM). However, alterations in characteristics of ASCs from the aforementioned T2DM patients are still obscure, which also hinder the rigorous and systematic illumination of progression and pathogenesis.
In this study, we originally isolated peripancreatic adipose tissue-derived mesenchymal stem cells from both human type 2 diabetic and non-diabetic donors (T2DM-ASCs, ND-ASCs) with the parental consent, respectively. We noticed that T2DM-ASCs exhibited indistinguishable immunophenotype, cell vitality, chondrogenic differentiation and stemness as ND-ASCs. Simultaneously, there's merely alterations in migration and immunoregulatory capacities in T2DM-ASCs. However, differing from ND-ASCs, T2DM-ASCs exhibited deficiency in adipogenic and osteogenic differentiation, and in particular, the delayed cell cycle and different cytokine expression spectrum.
The conservative alterations of T2DM-ASCs in multifaceted characteristics indicated the possibility of autologous application of ASCs for cell-based T2DM treatment in the future. |
| doi_str_mv | 10.15283/ijsc20028 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2418133188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2418133188</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-74b0712ed9151ecfcd2b122adf5f4ace1101fbb5623fc50b1184391e55de37543</originalsourceid><addsrcrecordid>eNo1kEtPwzAQhH0A0ar0wg9APnIJeO04cY5Vy0sqQoJyjhx7I1zlhZ1UqvjzGFH2MqvRtyPtEHIF7BYkV-LO7YPhjHF1RuZRZSIyls3IMoQ9iyMKVWTqgswElyoHIebke2Xd0AekOxfChMkGvTugpe8jtnSNTRNo7fuW7o4DUk43Tlc4OhPoGx5QN3TddwH9QY_xiq6aEX1co0ddR1-mZnTWtdiFaP3Cn9prExkXfjMuyXmtm4DLky7Ix8P9bv2UbF8fn9erbTJwgDHJ04rlwNEWIAFNbSyvgHNta1mn2iAAg7qqZMZFbSSrAFQqCkApLYpcpmJBbv5yB99_TRjGsnXBxN90h_0USp6CimWAUhG9PqFT1aItB-9a7Y_lf2HiBzQibRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2418133188</pqid></control><display><type>article</type><title>Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>KoreaMed Open Access</source><source>PubMed Central</source><creator>Wang, Le ; Zhang, Leisheng ; Liang, Xue ; Zou, Jiaqi ; Liu, Na ; Liu, Tengli ; Wang, Guanqiao ; Ding, Xuejie ; Liu, Yaojuan ; Zhang, Boya ; Liang, Rui ; Wang, Shusen</creator><creatorcontrib>Wang, Le ; Zhang, Leisheng ; Liang, Xue ; Zou, Jiaqi ; Liu, Na ; Liu, Tengli ; Wang, Guanqiao ; Ding, Xuejie ; Liu, Yaojuan ; Zhang, Boya ; Liang, Rui ; Wang, Shusen</creatorcontrib><description>Adipose tissue-derived mesenchymal stem cells (ASCs) are recognized as an advantaged source for the prevention and treatment of diverse diseases including type 2 diabetes mellitus (T2DM). However, alterations in characteristics of ASCs from the aforementioned T2DM patients are still obscure, which also hinder the rigorous and systematic illumination of progression and pathogenesis.
In this study, we originally isolated peripancreatic adipose tissue-derived mesenchymal stem cells from both human type 2 diabetic and non-diabetic donors (T2DM-ASCs, ND-ASCs) with the parental consent, respectively. We noticed that T2DM-ASCs exhibited indistinguishable immunophenotype, cell vitality, chondrogenic differentiation and stemness as ND-ASCs. Simultaneously, there's merely alterations in migration and immunoregulatory capacities in T2DM-ASCs. However, differing from ND-ASCs, T2DM-ASCs exhibited deficiency in adipogenic and osteogenic differentiation, and in particular, the delayed cell cycle and different cytokine expression spectrum.
The conservative alterations of T2DM-ASCs in multifaceted characteristics indicated the possibility of autologous application of ASCs for cell-based T2DM treatment in the future.</description><identifier>ISSN: 2005-3606</identifier><identifier>DOI: 10.15283/ijsc20028</identifier><identifier>PMID: 32587133</identifier><language>eng</language><publisher>Korea (South)</publisher><ispartof>International journal of stem cells, 2020-07, Vol.13 (2), p.268-278</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32587133$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Le</creatorcontrib><creatorcontrib>Zhang, Leisheng</creatorcontrib><creatorcontrib>Liang, Xue</creatorcontrib><creatorcontrib>Zou, Jiaqi</creatorcontrib><creatorcontrib>Liu, Na</creatorcontrib><creatorcontrib>Liu, Tengli</creatorcontrib><creatorcontrib>Wang, Guanqiao</creatorcontrib><creatorcontrib>Ding, Xuejie</creatorcontrib><creatorcontrib>Liu, Yaojuan</creatorcontrib><creatorcontrib>Zhang, Boya</creatorcontrib><creatorcontrib>Liang, Rui</creatorcontrib><creatorcontrib>Wang, Shusen</creatorcontrib><title>Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics</title><title>International journal of stem cells</title><addtitle>Int J Stem Cells</addtitle><description>Adipose tissue-derived mesenchymal stem cells (ASCs) are recognized as an advantaged source for the prevention and treatment of diverse diseases including type 2 diabetes mellitus (T2DM). However, alterations in characteristics of ASCs from the aforementioned T2DM patients are still obscure, which also hinder the rigorous and systematic illumination of progression and pathogenesis.
In this study, we originally isolated peripancreatic adipose tissue-derived mesenchymal stem cells from both human type 2 diabetic and non-diabetic donors (T2DM-ASCs, ND-ASCs) with the parental consent, respectively. We noticed that T2DM-ASCs exhibited indistinguishable immunophenotype, cell vitality, chondrogenic differentiation and stemness as ND-ASCs. Simultaneously, there's merely alterations in migration and immunoregulatory capacities in T2DM-ASCs. However, differing from ND-ASCs, T2DM-ASCs exhibited deficiency in adipogenic and osteogenic differentiation, and in particular, the delayed cell cycle and different cytokine expression spectrum.
The conservative alterations of T2DM-ASCs in multifaceted characteristics indicated the possibility of autologous application of ASCs for cell-based T2DM treatment in the future.</description><issn>2005-3606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo1kEtPwzAQhH0A0ar0wg9APnIJeO04cY5Vy0sqQoJyjhx7I1zlhZ1UqvjzGFH2MqvRtyPtEHIF7BYkV-LO7YPhjHF1RuZRZSIyls3IMoQ9iyMKVWTqgswElyoHIebke2Xd0AekOxfChMkGvTugpe8jtnSNTRNo7fuW7o4DUk43Tlc4OhPoGx5QN3TddwH9QY_xiq6aEX1co0ddR1-mZnTWtdiFaP3Cn9prExkXfjMuyXmtm4DLky7Ix8P9bv2UbF8fn9erbTJwgDHJ04rlwNEWIAFNbSyvgHNta1mn2iAAg7qqZMZFbSSrAFQqCkApLYpcpmJBbv5yB99_TRjGsnXBxN90h_0USp6CimWAUhG9PqFT1aItB-9a7Y_lf2HiBzQibRg</recordid><startdate>20200730</startdate><enddate>20200730</enddate><creator>Wang, Le</creator><creator>Zhang, Leisheng</creator><creator>Liang, Xue</creator><creator>Zou, Jiaqi</creator><creator>Liu, Na</creator><creator>Liu, Tengli</creator><creator>Wang, Guanqiao</creator><creator>Ding, Xuejie</creator><creator>Liu, Yaojuan</creator><creator>Zhang, Boya</creator><creator>Liang, Rui</creator><creator>Wang, Shusen</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200730</creationdate><title>Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics</title><author>Wang, Le ; Zhang, Leisheng ; Liang, Xue ; Zou, Jiaqi ; Liu, Na ; Liu, Tengli ; Wang, Guanqiao ; Ding, Xuejie ; Liu, Yaojuan ; Zhang, Boya ; Liang, Rui ; Wang, Shusen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-74b0712ed9151ecfcd2b122adf5f4ace1101fbb5623fc50b1184391e55de37543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Le</creatorcontrib><creatorcontrib>Zhang, Leisheng</creatorcontrib><creatorcontrib>Liang, Xue</creatorcontrib><creatorcontrib>Zou, Jiaqi</creatorcontrib><creatorcontrib>Liu, Na</creatorcontrib><creatorcontrib>Liu, Tengli</creatorcontrib><creatorcontrib>Wang, Guanqiao</creatorcontrib><creatorcontrib>Ding, Xuejie</creatorcontrib><creatorcontrib>Liu, Yaojuan</creatorcontrib><creatorcontrib>Zhang, Boya</creatorcontrib><creatorcontrib>Liang, Rui</creatorcontrib><creatorcontrib>Wang, Shusen</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of stem cells</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Le</au><au>Zhang, Leisheng</au><au>Liang, Xue</au><au>Zou, Jiaqi</au><au>Liu, Na</au><au>Liu, Tengli</au><au>Wang, Guanqiao</au><au>Ding, Xuejie</au><au>Liu, Yaojuan</au><au>Zhang, Boya</au><au>Liang, Rui</au><au>Wang, Shusen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics</atitle><jtitle>International journal of stem cells</jtitle><addtitle>Int J Stem Cells</addtitle><date>2020-07-30</date><risdate>2020</risdate><volume>13</volume><issue>2</issue><spage>268</spage><epage>278</epage><pages>268-278</pages><issn>2005-3606</issn><abstract>Adipose tissue-derived mesenchymal stem cells (ASCs) are recognized as an advantaged source for the prevention and treatment of diverse diseases including type 2 diabetes mellitus (T2DM). However, alterations in characteristics of ASCs from the aforementioned T2DM patients are still obscure, which also hinder the rigorous and systematic illumination of progression and pathogenesis.
In this study, we originally isolated peripancreatic adipose tissue-derived mesenchymal stem cells from both human type 2 diabetic and non-diabetic donors (T2DM-ASCs, ND-ASCs) with the parental consent, respectively. We noticed that T2DM-ASCs exhibited indistinguishable immunophenotype, cell vitality, chondrogenic differentiation and stemness as ND-ASCs. Simultaneously, there's merely alterations in migration and immunoregulatory capacities in T2DM-ASCs. However, differing from ND-ASCs, T2DM-ASCs exhibited deficiency in adipogenic and osteogenic differentiation, and in particular, the delayed cell cycle and different cytokine expression spectrum.
The conservative alterations of T2DM-ASCs in multifaceted characteristics indicated the possibility of autologous application of ASCs for cell-based T2DM treatment in the future.</abstract><cop>Korea (South)</cop><pmid>32587133</pmid><doi>10.15283/ijsc20028</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2005-3606 |
| ispartof | International journal of stem cells, 2020-07, Vol.13 (2), p.268-278 |
| issn | 2005-3606 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2418133188 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; KoreaMed Open Access; PubMed Central |
| title | Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adipose%20Tissue-Derived%20Stem%20Cells%20from%20Type%202%20Diabetics%20Reveal%20Conservative%20Alterations%20in%20Multidimensional%20Characteristics&rft.jtitle=International%20journal%20of%20stem%20cells&rft.au=Wang,%20Le&rft.date=2020-07-30&rft.volume=13&rft.issue=2&rft.spage=268&rft.epage=278&rft.pages=268-278&rft.issn=2005-3606&rft_id=info:doi/10.15283/ijsc20028&rft_dat=%3Cproquest_pubme%3E2418133188%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2418133188&rft_id=info:pmid/32587133&rfr_iscdi=true |